Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...
Marketing claims in AI rarely survive contact with reality. That’s because making real progress in healthcare is hard. To ...
The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself.
Three Vectors of Urban Transformation,” published in Applied Sciences, explores how cities are entering a new phase of technological evolution driven by the convergence of agentic artificial ...
SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal ...
Morning Overview on MSN
Amazon launches Bio Discovery AI tool for drug research
Amazon has reportedly developed an artificial intelligence platform called Bio Discovery, designed to help drug researchers ...
The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...
Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...
The $25B initiative could redefine chip manufacturing at scale, but supply constraints and long timelines likely mean IT ...
Major release delivers seamless Ignition SCADA, enterprise-grade security, advanced ML algorithms, and private cloud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results